Navigation Links
New Cancer Drug Boosts Blood Pressure
Date:1/3/2008

mber for the The Lancet study, sunitinib's maker, Pfizer Inc., agreed that these heart risks do exist. However, the company added that the cardiovascular events "were medically manageable in most patients and underscore the importance of having a collaborative team of health-care professionals working together to appropriately manage patients who have limited available options" in treating their cancer.

In the statement, Pfizer added that, "Lower incidences of cardiovascular effects have been observed in subsequent randomized Phase 3 prospective Sutent [sunitinib] studies in both renal cell carcinoma and gastrointestinal stromal tumor[s]." That includes a lower incidence of events such as congestive heart failure, impaired heart function, and high blood pressure that were noted in Chen's retrospective analysis, the company said.

More information

For more on sunitinib, visit the U.S. National Library of Medicine.



SOURCES: Michel Azizi, M.D., Ph.D., professor, vascular medicine, Georges Pompidou European Hospital, Paris; Ming Hui Chen, M.D., assistant professor, medicine, Harvard Medical School, Cardiology Department, Children's Hospital Boston; Jan. 3, 2008, New England Journal of Medicine


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Cancer Drug Boosts Blood Pressure
(Date:1/22/2015)... 2015 Angelweddingdress is a famous wedding dress ... customers to follow it on Facebook, Twitter, and Pinterest. The ... gift. Angelweddingdress draws a lottery every week. , Moreover, the ... 28, 2015. Click Angelweddingdress homepage for more information. ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David Leadbetter ... to bestow a Juvent Sports Achievement award upon an ... The award commemorated and congratulated McKitrick for her record ... her first amateur tournament in 1979 and most recently ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that ... And for those same twenty-plus years, the team at Doctors ... with the best possible doctor. With the combined breadth ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Yesterday, ... Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were honored ... leadership in advancing biotechnology, biomedical science, medical device ... Olsen each received the “2014 Life Sciences Champion” ...
(Date:1/22/2015)... WASHINGTON, DC (PRWEB) January 22, 2015 ... conditions in vulnerable communities and cause financial distress to ... report by analysts at Howard University’s Center on Race ... of dollars in economic activity, payday loans at the ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... , NEW YORK , Feb. ... Justice and Democracy: , A group of medical malpractice survivors, many ... a result of medical negligence, today sent letters to President Obama ... out of the health insurance reform bill.  They said that responding ...
... to attend school should not be given doctors, sick ... International (Dtsch Arztebl Int 2010; 107[4]), child and ... of school avoidance and describe measures to tackle the ... occurs frequently and is accompanied by psychiatric symptoms. Children ...
... tongue of a fruit fly could provide big answers to ... ways to treat obesity, according to a study from a ... the rank of Distinguished Professor of Biology, along with colleagues ... organs on Drosophila ,s proboscis (tongue), which triggers the ...
... AUGUSTA, Ga. Medical College of Georgia researchers are conducting ... of stem cells from umbilical cord blood can improve the ... The study will include 40 children age 2-12 whose parents ... Tucson, Ariz. Umbilical cord blood is rich in ...
... experts say drug has gotten ,bad rap, , THURSDAY, Feb. ... high risk of developing breast cancer take tamoxifen to prevent the ... have known since 1998 that tamoxifen can cut the risk of ... a surprise to me," said Dr. Jay Brooks, chairman of hematology/oncology ...
... lifesaving qualities, expert stresses , THURSDAY, Feb. 11 (HealthDay ... for three decades to treat the disease -- appears ... a new study has found. , "Our results are ... is known to be an important precondition for well-being," ...
Cached Medicine News:Health News:Medical Malpractice Survivors Urge President Obama to Keep 'Tort Reform' out of Health Insurance Bill 2Health News:Tiny fruit fly could offer big clues in fight against obesity, researcher says 2Health News:MCG to conduct first FDA-approved stem cell trial in pediatric cerebral palsy 2Health News:Few Women at High Risk for Breast Cancer Take Tamoxifen 2Health News:Few Women at High Risk for Breast Cancer Take Tamoxifen 3Health News:Cognitive Skills May Shrink With Tamoxifen 2Health News:Cognitive Skills May Shrink With Tamoxifen 3
(Date:1/23/2015)... , January 23, 2015 Heptares Therapeutics, the ... to announce that the Malcolm Campbell Memorial Prize ... (Vice President of Chemistry), Fiona Marshall (Chief Scientific ... Officer and co-founder) for the seminal contributions to GPCR drug ...
(Date:1/22/2015)... Jan. 22, 2015  ResMed Inc. (NYSE: RMD ) ... Revenue for the quarter was $423.0 million, a 10 percent ... 14 percent increase on a constant currency basis). Net income ... the quarter ended December 31, 2013. Diluted earnings per share ...
(Date:1/22/2015)... 2015 Increasing sophistication among enterprise buyers of language ... in 2015, says Moravia CMO, Renato ... by market research firm Common Sense Advisory, 15 percent ... translation and localization needs. "From a language industry perspective, ...
Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
... enables sustained,Interferon-beta production from muscle cells - ... disease, NEW ORLEANS--(BUSINESS WIRE)--Mar 26, 2007 - ... at the American College of,Cardiology's 58th Annual ... DNA encoding the anti-inflammatory protein,interferon-beta (IFN-beta) using ...
... Mass.--(BUSINESS WIRE)--Mar 27, 2007 - Inotek,Pharmaceuticals Corporation ... clinical data demonstrating the safety of INO-1001,as ... a preventative agent for,cardiac reperfusion injury. The ... myocardial infarction (STEMI) undergoing,primary percutaneous coronary intervention. ...
Cached Medicine Technology:Interferon Beta DNA Treatment Delivered with Ichor Technology,Reduces Atherosclerosis Progression in Mice 2Interferon Beta DNA Treatment Delivered with Ichor Technology,Reduces Atherosclerosis Progression in Mice 3Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 2Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 3Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 4
... peripheral nerve stimulator from B. Braun Medical. It ... advanced digital technology. , ,Your ability to ... the localization of practically all mixed nerves for ... additional optional component for the HNS11 is a ...
Based on the original MS-1 design the new MS-1B includes low battery detection, FET based output circuitry and enhanced battery compartment....
... allows hands-free operation in nerve locator mode., ... mA) with SoloStim provides a wide range ... when close to nerve., ,Supported by ... products, including the clinically proven ProBloc™ single ...
... The Aisys Carestation helps you deliver unmatched ... Aisys Carestation is the most complete anesthesia ... point of need - at your fingertips., ... our industry-leading Datex-Ohmeda legacy of anesthesia delivery ...
Medicine Products: